Evaluation of cardioprotective effects of carvedilol in dogs receiving doxorubicin chemotherapy: A prospective, randomized, double-blind, placebo controlled pilot study.

Research in Veterinary Science
Eloisa Helena M PinoDaniel G Gerardi

Abstract

The aim of this pilot study was to evaluate the cardioprotective effects of carvedilol in dogs receiving doxorubicin chemotherapy and provide suggestions to future studies based on results and limitations of our study. Thirteen dogs were randomized into two experimental groups: 6 dogs in carvedilol group and 7 dogs in placebo group. In carvedilol group, 0.39 mg/kg ± 0.04 twice-daily oral carvedilol was started on the day of the first doxorubicin treatment and continued throughout the chemotherapy protocol until the final cardiological evaluation. Cardiological evaluations were performed before the first doxorubicin administration and then 10 to 15 days after each subsequent dose. Troponin I and oxidative stress tests were performed with serum collected from dogs at the initial and final cardiological evaluation. Carvedilol produced some echocardiographic and electrocardiographic changes (reduced E velocity and E/IVRT ratio, as well reduced heart rate and increased PR and QT interval) due to its beta-block effect. In placebo group Doppler study showed a significant increase in mitral flow deceleration time (EDT), as well increased amplitude of the S wave in the right, and R wave in the left, precordial chest leads. There were si...Continue Reading

References

Jan 1, 1992·Free Radical Research Communications·E LissiM D Del Castillo
Mar 1, 1992·Journal of Veterinary Internal Medicine·G E MauldinR E Matus
Jan 1, 1990·Methods in Enzymology·R L LevineE R Stadtman
Dec 1, 1990·Biochemical Society Transactions·C W Mulholland, J J Strain
Jan 1, 1990·Methods in Enzymology·H Esterbauer, K H Cheeseman
Jan 1, 1987·Journal of the American College of Cardiology·B H LeeR T Skeel
Feb 1, 1996·The Journal of Toxicological Sciences·K HanaiM Matsuo
Jul 20, 2002·The Journal of Veterinary Medical Science·Masami UechiYumi Ishikawa
Sep 27, 2002·Toxicology·José L QuilesM Carmen Ramírez-Tortosa
Dec 25, 2002·Toxicology and Applied Pharmacology·D L SantosK B Wallace
Mar 1, 1959·Circulation·G R CUMMING, W L PROUDFIT
Jan 1, 1961·Cleveland Clinic Quarterly·A J GEORGOPOULOSW L PROUDFIT
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·James E Klaunig, Lisa M Kamendulis
Sep 24, 2004·Journal of Molecular and Cellular Cardiology·Paolo SpallarossaClaudio Brunelli
Oct 13, 2004·Toxicology and Applied Pharmacology·Paulo J OliveiraKendall B Wallace
Nov 10, 2004·Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine·M SzczubiałJ Lipko
May 20, 2005·American Journal of Veterinary Research·Jonathan A AbbottR Lee Pyle
May 26, 2005·Cancer Letters·Péter VajdovichJudit Jakus
Aug 3, 2006·American Journal of Veterinary Research·Rute Chamié Alves de Souza, Aparecido Antonio Camacho
Dec 13, 2006·Journal of the American College of Cardiology·Nihat KalayAli Ergin
Jan 27, 2007·Cardiovascular Ultrasound·Maurizio GalderisiOreste de Divitiis
Nov 26, 2008·Analytical Biochemistry·Maria T K DreschJosé C F Moreira
Nov 1, 2002·Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology·Valérie Chetboul
Feb 13, 2009·Journal of Veterinary Internal Medicine·J L WinterJ B Blumberg
May 2, 2009·Toxicological Sciences : an Official Journal of the Society of Toxicology·Mehdi S HazariAimen K Farraj
Sep 17, 2009·Journal of Veterinary Pharmacology and Therapeutics·M MartinezR P Hunter
Sep 29, 2009·Journal of Veterinary Internal Medicine·C AtkinsR Stepien
Dec 18, 2009·Cardiology·Kanu ChatterjeeJoel S Karliner
Nov 11, 2010·Veterinary and Comparative Oncology·W M FitzPatrickB E Kitchell
Sep 2, 2011·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·Asli TanindiMustafa Benekli
Jan 24, 2012·Journal of the American Animal Hospital Association·William RatterreeKeith Strickland

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Family Medicine
S G Crysant
Deutsche medizinische Wochenschrift
W AntepohlM Böhm
The New England Journal of Medicine
W H Frishman
Indian Heart Journal
W H Frishman
The New England Journal of Medicine
L J Cohn
© 2021 Meta ULC. All rights reserved